Ignite Creation Date:
2024-05-06 @ 1:06 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03930771
Status:
TERMINATED
Last Update Posted:
2022-08-09
First Post:
2019-04-25
Brief Title:
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
Sponsor:
Weill Medical College of Cornell University
Organization:
Weill Medical College of Cornell University
Organization Data
Organization:
Weill Medical College of Cornell University
Class:
OTHER
Study ID:
1809019558
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Weill Medical College of Cornell University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None